cgp 12177 has been researched along with Chronic Disease in 2 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papp, M | 1 |
| Nalepa, I | 1 |
| Vetulani, J | 1 |
| León-Velarde, F | 1 |
| Bourin, MC | 1 |
| Germack, R | 1 |
| Mohammadi, K | 1 |
| Crozatier, B | 1 |
| Richalet, JP | 1 |
2 other studies available for cgp 12177 and Chronic Disease
| Article | Year |
|---|---|
Reversal by imipramine of beta-adrenoceptor up-regulation induced in a chronic mild stress model of depression.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Cerebral Cortex; Chronic Disease; Depressio | 1994 |
Differential alterations in cardiac adrenergic signaling in chronic hypoxia or norepinephrine infusion.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cholera Toxin; Chroni | 2001 |